BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/5/2022 2:53:48 AM | Browse: 759 | Download: 1669
 |
Received |
|
2021-06-02 19:27 |
|
Peer-Review Started |
|
2021-06-02 19:30 |
|
First Decision by Editorial Office Director |
|
2021-07-31 03:58 |
|
Return for Revision |
|
2021-07-31 03:58 |
|
Revised |
|
2021-08-04 15:47 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-12-13 03:30 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-12-23 05:46 |
|
Articles in Press |
|
2021-12-23 05:46 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-12-31 08:38 |
|
Publish the Manuscript Online |
|
2022-01-05 02:53 |
| ISSN |
2220-3141(online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Noncommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Urology & Nephrology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Efficacy of remdesivir for hospitalized COVID-19 patients with end stage renal disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Vijairam Selvaraj, Amos Lal, Arkadiy Finn, Joshua Ray Tanzer, Muhammad Baig, Atin Jindal, Kwame Dapaah-Afriyie and George Bayliss |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Amos Lal, FACP, MBBS, Assistant Professor, Medicine, Division of Pulmonary and Critical Care, Mayo Clinic, 200 1st St SW, Rochester, Minnesota 55905, United States. manavamos@gmail.com |
| Key Words |
COVID-19; Remdesivir; End stage renal disease; Dialysis; Hemodialysis; Kidney disease |
| Core Tip |
Little known information exists regarding the efficacy of remdesivir in corona virus disease 2019 patients with end stage renal disease on dialysis. Use of remdesivir was associated with a trend towards reduced oxygen requirement, reduced probability of progression to mechanical ventilation and better prognosis. Larger studies are justified in this high risk, vulnerable population. |
| Publish Date |
2022-01-05 02:53 |
| Citation |
Selvaraj V, Lal A, Finn A, Tanzer JR, Baig M, Jindal A, Dapaah-Afriyie K, Bayliss G. Efficacy of remdesivir for hospitalized COVID-19 patients with end stage renal disease. World J Crit Care Med 2022; 11(1): 48-57 |
| URL |
https://www.wjgnet.com/2220-3141/full/v11/i1/48.htm |
| DOI |
https://dx.doi.org/10.5492/wjccm.v11.i1.48 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
